Group structure
6 companies in 2 countries
United States4
Canada1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading your page…
Loading your page…
6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALSUMA6mg base/0.5ml (eq 12mg base/ml) · Injectable | Sumatriptan | United States | Not marketed | 2010 |
| IDKIT:HP4gm; 13 75mg · For solution, tablet, for solution | Citric acid, C-urea | United States | Marketed | 2002 |
| LIDOPEN10% · Injectable | Lidocaine | United States | Not marketed | 1975 |
| MORPHINE SULFATE (AUTOINJECTOR)10mg/0.7ml (10mg/0.7ml) · Solution | Morphine | United States | Not marketed | 1990 |
| PRALIDOXIME CHLORIDE (AUTOINJECTOR)600mg/2ml (300mg/ml) · Solution | Pralidoxime | United States | Not marketed | 1983 |
| EpiPen 150 mcg per 0.3 ml | Epinephrine | Saudi Arabia | Authorised | |
| EpiPen 300 mcg per 0.3 ml | Epinephrine | Saudi Arabia | Authorised | |
| DIAZEPAM AUTOINJECTOR10 mg / 2 ml · Liquid | Diazepam | Canada | Cancelled | 2007 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 5 | 0 | CompaniesAll medicines |
| Saudi Arabia | 2 | 2 | 0 | CompaniesAll medicines |
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.